Exametazime

In the US, Exametazime.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0105613-48-7

Chemical Formula

C13-H28-N4-O2

Molecular Weight

272

Therapeutic Categories

Diagnostic agent

Radiodiagnostic agent

Chemical Name

2-Butanone, 3,3'-[(2,2-dimethyl-1,3-propanediyl)diimino]bis-, dioxime, [R*,R*-(E,E)]-(±)-

Foreign Names

• Exametazimum (Latin)
• Exametazim (German)
• Examétazime (French)
• Exametazima (Spanish)

Generic Names

• Exametazime (OS: BAN, USAN, JAN)
• Examétazime (OS: DCF)
• dl-HM-PAO (IS)
• Esametazima (IS)
• Hexametazime (IS)
• HM-PAO (IS)
• Technetium Tc 99m Exametazime (OS: USAN)
• Tc 99m HM-PAO (IS)
• Technetium Tc 99m Exametazime Injection (PH: BP 2003, Ph. Eur. 5, USP 32)

Brand Names

• Cerestab
  Amersham, France



• Ceretec
  Amersham, Romania; GE Healthcare, Australia; GE Healthcare, Bulgaria; GE Healthcare, Switzerland; GE Healthcare, France; GE Healthcare, Italy; GE Healthcare, Lithuania; GE Healthcare, Malta; Amersham, Spain

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.